• Citer

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy

par Seremet, Teofila T.C.;Neyns, Bart;Planken, Simon;Schreuer, Max M.S.;Jansen, Yanina Y.J.;Delaunoy, Melanie ;El Housni, Hakim ;Lienard, Danielle ;Del Marmol, Véronique ;Heimann, Pierre
Référence Melanoma research, 28, 1, page (65-70)
Publication Publié, 2018

Article révisé par les pairs

• Détails
• Contenu

Titre:	Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy
Auteur:	Seremet, Teofila T.C.; Neyns, Bart; Planken, Simon; Schreuer, Max M.S.; Jansen, Yanina Y.J.; Delaunoy, Melanie; El Housni, Hakim; Lienard, Danielle; Del Marmol, Véronique; Heimann, Pierre
Informations sur la publication:	Melanoma research, 28, 1, page (65-70)
Statut de publication:	Publié, 2018
Sujet CREF:	Cancérologie
	Dermatologie
Mots-clés:	BRAF/NRAS mutations monitoring
	circulating tumor DNA
	immunotherapy
	liquid biopsy
	metastatic melanoma
	monitoring
	translational research
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0960-8931
	info:doi/10.1097/CMR.0000000000000415
	info:scp/85042357022